David Eansor

2019

In 2019, David Eansor earned a total compensation of $2.3M as Senior Vice President Biotechnology at Bio-Techne, a 46% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$613,448
Option Awards$900,053
Salary$501,380
Stock Awards$299,907
Other$8,250
Total$2,323,038

Eansor received $900.1K in option awards, accounting for 39% of the total pay in 2019.

Eansor also received $613.4K in non-equity incentive plan, $501.4K in salary, $299.9K in stock awards and $8.3K in other compensation.

Rankings

In 2019, David Eansor's compensation ranked 5,196th out of 13,971 executives tracked by ExecPay. In other words, Eansor earned more than 62.8% of executives.

ClassificationRankingPercentile
All
5,196
out of 13,971
63rd
Division
Manufacturing
1,936
out of 5,692
66th
Major group
Chemicals And Allied Products
680
out of 2,189
69th
Industry group
Drugs
571
out of 1,875
70th
Industry
Biological Products, Except Diagnostic Substances
129
out of 389
67th
Source: SEC filing on September 9, 2019.

Eansor's colleagues

We found four more compensation records of executives who worked with David Eansor at Bio-Techne in 2019.

2019

Charles Kummeth

Bio-Techne

Chief Executive Officer

2019

James Hippel

Bio-Techne

Chief Financial Officer

2019

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

2019

Brenda Furlow

Bio-Techne

General Counsel

News

You may also like